Jichuan Pharmaceutical (600566.SH): Pediatric faropenem sodium granules and injectable cefazoxime sodium obtained drug registration certificates

Zhitongcaijing · 12/12/2024 09:33

Zhitong Finance App News, Jichuan Pharmaceutical (600566.SH) announced that Jichuan Pharmaceutical Group Co., Ltd. (“Jichuan Limited”) and Shaanxi Dongke Pharmaceutical Co., Ltd. (“Dongke Pharmaceutical”), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for pediatric faropenem sodium granules and the “Drug Registration Certificate” for injectable cefazoxime sodium approved and issued by the State Drug Administration.